Could a simple switch ease dry eye suffering?
NCT ID NCT07267481
First seen Jan 11, 2026 · Last updated Apr 30, 2026 · Updated 12 times
Summary
This study looks at whether switching from the dry eye drop Xiidra to a new drop called TRYPTYR (acoltremon 0.003%) can better improve symptoms and tear production. About 100 adults who have used Xiidra for at least a month will be switched to TRYPTYR and monitored for 28 days. The goal is to see if the new drop provides greater relief from dry eye signs and discomfort.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.